← Evidence map

ArticleBMB reports2025

Erratum to: Celecoxib is the only nonsteroidal anti-inflammatory drug to inhibit bone progression in spondyloarthritis.

Jin Sun Choi et al.PubMed ↗Full text ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40296671